Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

NCT00539006 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: FPNS
DRUG: FFNS
DRUG: placebo FPNS
DRUG: placebo FFNS

Sponsor

GlaxoSmithKline